Jpmorgan Chase & CO Cocrystal Pharma, Inc. Transaction History

Jpmorgan Chase & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.27 - $3.6 $1,152 - $15,372	-4,270 Reduced 51.66%	3,995 $1,000
Q2 2022 Aug 11, 2022	SELL	$0.38 - $0.55 $758 - $1,097	-1,996 Reduced 19.45%	8,265 $3,000
Q1 2022 May 11, 2022	SELL	$0.48 - $0.71 $23,855 - $35,285	-49,698 Reduced 82.89%	10,261 $6,000
Q4 2021 Feb 10, 2022	BUY	$0.65 - $1.02 $38,231 - $59,994	58,818 Added 5154.95%	59,959 $39,000
Q3 2021 Nov 12, 2021	BUY	$1.01 - $1.25 $1,152 - $1,426	1,141 New	1,141 $1,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $17.5M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.